Browse > Article
http://dx.doi.org/10.9719/EEG.2015.48.3.221

Case Study of Pharmaceutical Ingredients Derived from Clay Minerals  

Jin, Su-Eon (College of Pharmacy, Yonsei University)
Lee, Jangik Ike (College of Pharmacy, Yonsei University)
Hwang, Sung-Joo (College of Pharmacy, Yonsei University)
Publication Information
Economic and Environmental Geology / v.48, no.3, 2015 , pp. 221-229 More about this Journal
Abstract
Clay minerals have been used in pharmaceutical industries as active ingredients and excipients without pharmacological activity such as diluents, emulsifying agents, viscosity-increasing agents, and lubricants. For example, bentonite, kaolin, magnesium aluminum silicate, and talc are generally and extensively used pharmaceutical ingredients, which are restrictedly regulated by Pharmacopoeias. We discuss the physicochemical and biopharmaceutical properties of clay minerals. In addition, we introduce the cases of pharmaceutical applications of clay minerals. From this review, pharmaceutical applications of clay minerals can be one of strategies for the development of high value-added products from clay minerals.
Keywords
clay minerals; pharmacy; pharmacopoeia; active ingredients; pharmaceutical excipients;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Al-khattawi, A. and Mohammed, A.R. (2013) Compressed orally disintegrating tablets: excipients evolution and formulation strategies. Expert Opinion on Drug Delivery, v.10, p.651-663.   DOI
2 Bailey, SW. (1980) Summary of recommendations of AIPEA [Association Internationale Pour l'Etude des Argiles] nomenclature committee on clay. American Mineralogist, v.65, p.1-7.
3 Calabrese, I., Cavallaro, G., Scialabba, C., Licciardi, M., Merli, M., Sciascia, L., Turco, and Liveri, M.L. (2013) Montmorillonite nanodevices for the colon metronidazole delivery. International Journal of Pharmaceutics, v.457, p.224-236.   DOI
4 Campbell, K.T., Craig, D.Q. and McNally, T. (2010) Ibuprofen-loaded poly(epsilon-caprolactone) layered silicate nanocomposites prepared by hot melt extrusion. Journal of Materials Science: Materials in Medicine. v.21, p.2307-2316.   DOI
5 Carretero, M.I. and Pozo, M. (2010) Clay and non-clay minerals in the pharmaceutical and cosmetic industries Part II. Active ingredients. Applied Clay Science, v.47, p.171-181.   DOI
6 Carretero, M.I. and Pozo, M. (2009) Clay and non-clay minerals in the pharmaceutical industry: Part I. Excipients and medical applications. Applied Clay Science, v.46, p.73-80.   DOI
7 Dogan, M., Dogan, A.U., Aburub, A., Botha, A. and Wurster, D.E. (2012) Quantitative mineralogical properties (morphology-chemistry-structure) of pharmaceutical grade kaolinites and recommendations to regulatory agencies. Microscopy and Microanalysis, v.18, p.143-151.   DOI
8 Dvinskikh, S.V., Szutkowski, K. and Fur, I. (2009) MRI profiles over very wide concentration ranges: application to swelling of a bentonite clay. Journal of Magnetic Resonance, v.198, p.146-150.   DOI
9 Elmore, A.R. (2003) Cosmetic Ingredient Review Expert Panel. Final report on the safety assessment of aluminum silicate, calcium silicate, magnesium aluminum silicate, magnesium silicate, magnesium trisilicate, sodium magnesium silicate, zirconium silicate, attapulgite, bentonite, Fuller's earth, hectorite, kaolin, lithium magnesium silicate, lithium magnesium sodium silicate, montmorillonite, pyrophyllite, and zeolite. International Journal of Toxicology, v.22, p.37-102.   DOI
10 el-Sayed, A.M., Ismael, A. el-M. and Assi A. el-A. (1993) Dissociation constant of chlordiazepoxide in montmorillonite suspension and its pharmaceutical application for a controlled-release dosage form. Acta pharmaceutica Hungarica, v.63, p.257-266.
11 Goel, H., Rai, P., Rana, V. and Tiwary, A.K. (2008) Orally disintegrating systems: innovations in formulation and technology. Recent Patents on Drug Delivery & Formulation, v.2, p.258-274.   DOI
12 Hajizadeh, SHajizadeh S., Shiran, K. and Fathollahi, Y. (2005) Responsiveness of vascular alpha1-adrenoceptors of diabetic rat knee joint to phenylephrine in acute inflammation. Journal of Basic and Clinical Physiology and Pharmacology, v.16, p.301-309.
13 Hong, Y., Ji, H. and Wei, H. (2006) Topical ketanserin attenuates hyperalgesia and inflammation in arthritis in rats. Pain, v.124, p.27-33.   DOI
14 Hopkins, J.G. (1946) Some Newer Bases for Use in Cutaneous Therapy. Journal of Investigative Dermatology, v.7, p.171-174.   DOI
15 Loyd, V. Allen, Jr. Nicholas, G. Popovich, and Howard, C. Ansel (2011) Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems, 9th Ed. Lippincott Williams & Wilkins, a Wolters Kluwer business, USA. p.107-188.
16 Masanaba, S., Pichardo, S., Puerto, M., Gutirrez-Praena, D., Camen, A.M. and Jos, A. (2015) Toxicological evaluation of clay minerals and derived nanocomposites: a review. Environmental Research, v.138, p.233-254.   DOI
17 Moyo, F., Tandlich, R., Wilhelmi, B.S. and Balaz, S. (2014) Sorption of hydrophobic organic compounds on natural sorbents and organoclays from aqueous and nonaqueous solutions: a mini-review. International Journal of Environmental Research and Public Health, v.11, p.5020-5048.   DOI
18 Paineau, E., Bihannic, I., Baravian, C., Philippe, A.M., Davidson, P., Levitz, P., Funari, S.S., Rochas, C. and Michot, L.J. (2011) Aqueous suspensions of natural swelling clay minerals. 1. Structure and electrostatic interactions. Langmuir, v.27, p.5562-5573.   DOI
19 Oh, Y.J., Choi, G., Choy, Y.B., Park, J.W., Park, J.H., Lee, H.J., Yoon, Y.J., Chang, H.C. and Choy, J.H. (2013) Aripiprazole-montmorillonite: a new organic-inorganic nanohybrid material for biomedical applications. Chemistry, v.19, p.4869-4875.   DOI
20 Otto, C.C. and Haydel, S.E. (2013) Exchangeable ions are responsible for the in vitro antibacterial properties of natural clay mixtures. PLoS One, v.17, e64068.
21 Rieder, M., Cavazzini, G., D'yakonov, Y.S., Frank-Kamenetskii, V.A., Gottardi, G., Guggenheim, S., Koval, P.V., Mller, G., Neiva, A.M.R., Radoslovich, E.W., Robert, J.L., Sassi, F.P., Takeda, H., Weiss, Z. and Wones, D.R. Nomenclature of micas. Clays and Clay Minerals, v.46, p.586-595.
22 Rodrigues, L.A., Figueiras, A., Veiga, F., de Freitas, R.M., Nunes, L.C., da Silva, Filho E.C. and da Silva, Leite C.M. (2013) The systems containing clays and clay minerals from modified drug release: a review. Colloids and Surfaces B: Biointerfaces, v.103, p.642-651.   DOI
23 Valenti, D.M., Silva, J., Teodoro, W.R., Velosa, A.P. and Mello, S.B. (2012) Effect of topical clay application on the synthesis of collagen in skin: an experimental study. Clinical and Experimental Dermatology, v.37, p.164-168.   DOI
24 Viseras, C. and Lpez-Galindo, A. (2000) Characteristics of pharmaceutical grade phyllosilicate powders. Pharmaceutical Development and Technology, v.5, p.47-52.   DOI
25 Viseras, C., Meeten, G.H. and Lopez-Galindo, A. (1999) Pharmaceutical grade phyllosilicate dispersions: the influence of shear history on floc structure. International Journal of Pharmaceutics, v.182, p.7-20.   DOI